Observational studyDermatology (Basel, Switzerland)2024

Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study.

Emilio Berna-Rico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.